Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(22/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(22/week)
News
United States
(499/week)
Manufacturing
(342/week)
Energy
(283/week)
Technology
(381/week)
Alternative Energy
(143/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Oncolytic adenovirus
Jun 04, 2020
Targovax Enters Collaboration With Leidos to add Checkpoint Inhibitor Functionality to ONCOS Viruses
Apr 27, 2020
Valo Therapeutics to Support Development of a Pan - Coronavirus Vaccine
Apr 22, 2020
Targovax and Valo Therapeutics Enter Collaboration to Develop RAS Neoantigen Coating of ONCOS Viruses Using PeptiCRAd Technology
Feb 06, 2020
Valo Therapeutics Announces New Funding for Immuno-Oncology Trials
Jan 13, 2020
DNAtrix Appoints Jeff Knapp as Chief Executive Officer and to Board of Directors
Nov 28, 2019
WuXi ATU and GeneMedicine Sign Development and Manufacturing Agreement for Oncolytic Virus Products
Nov 24, 2019
DNAtrix Presents Positive Results from the Phase 2 CAPTIVE/KEYNOTE-192 Study of DNX-2401 in Combination with Pembrolizumab for Glioblastoma at the 2019 SNO Annual Meeting
Nov 11, 2019
DNAtrix to Present Updated Results from the Phase 2 CAPTIVE / KEYNOTE-192 Study of DNX-2401 in Combination with Pembrolizumab for Glioblastoma at the 2019 SNO Annual Meeting
Sep 02, 2019
Valo Therapeutics Acquires PeptiENV Technology from the University of Helsinki
Jun 17, 2019
Valo Therapeutics Appoints Michael Stein as Chief Executive Officer
Apr 30, 2019
Tessa Therapeutics, in Collaboration with Baylor College of Medicine, Presents Preclinical Results Showing Enhanced T Cell Responses Against HER2-Positive Solid Tumors Using Novel Combination CAR T Cell Therapy
Nov 26, 2018
Alcyone Lifesciences Announces the Use of AMC Intratumoral Delivery Platform in the Treatment of First Patient in DNX-2440 Glioblastoma Trial
Nov 13, 2018
DNAtrix and Valo Therapeutics Enter into Strategic Partnership to Develop Peptide-Coated Oncolytic Viruses for Treating Cancer
Nov 07, 2018
Effectiveness of DNAtrix's DNX-2440 Oncolytic Virus Expressing OX40L in Solid Tumors to be Presented at the 2018 Annual Meeting of the Society for Immunotherapy of Cancer
Sep 12, 2018
Targovax Announces Publication of New Oncolytic Virus Data in the Journal of Medical Virology and Cancer Gene Therapy
Jul 12, 2018
Targovax and SOTIO Announce First Patient Dosed in Phase I/II Combination Trial of ONCOS-102 With DCVAC
Jun 11, 2018
Targovax Strengthens Focus on ONCOS Oncolytic Virus Development Program
May 10, 2018
Vyriad to Build State-of-the-Art Facility for Manufacturing Oncolytic Virus Anti-Cancer Vaccines in Rochester, Minn.
May 08, 2018
Successful Delivery of DNAtrix's Oncolytic Virus DNX-2401 to Pediatric Brain Tumors
Apr 12, 2018
Effectiveness of DNAtrix Oncolytic Virus DNX-2440 Armed with OX40L to be Presented at the 2018 Annual Meeting of the American Association for Cancer Research
Page 1
››
Latest News
May 17, 2024
Halliburton Annual Meeting of Shareholders and Dividend Declaration
May 17, 2024
NGL Energy Partners Announces Earnings Call
May 17, 2024
Piedmont Announces Upcoming Conference Participation
May 17, 2024
dynaCERT Launches $2,500,000 Non-Brokered Private Placement of Equity
May 17, 2024
Materion to Participate in KeyBanc’s Industrials and Basic Materials Conference
May 17, 2024
NW Natural and Modern Hydrogen Unveil Clean Hydrogen Production, Carbon Capture Project in Portland
May 17, 2024
AltaLink, L.P. to issue $325 Million in Senior Secured Notes
May 17, 2024
Cadre Holdings Announces Participation at Upcoming Investor Conferences
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events